Acceder Registro /

ANA BELÉN PÉREZ OLIVA

Buscador

Martinez-Balsalobre E, Guervilly JH, van Asbeck-van der Wijst J, Perez-Oliva AB, Lachaud C. Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer? Blood Rev. 2023 Jul;60:101094. doi: 10.1016/j.blre.2023.101094. Epub 2023 Apr 28. PubMed PMID: 37142543.
AÑO: 2023; IF: 7.4
Rodriguez-Ruiz L, Lozano-Gil JM, Naranjo-Sanchez E, Martinez-Balsalobre E, Martinez-Lopez A, Lachaud C, Blanquer M, Phung TK, Garcia-Moreno D, Cayuela ML, Tyrkalska SD, Perez-Oliva AB, Mulero V. ZAKalpha/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome. EMBO Mol Med. 2023 Oct 11;15(10):e18142. doi: 10.15252/emmm.202318142. Epub 2023 Sep 7. PubMed PMID: 37675820; PubMed Central PMCID: PMC10565642.
AÑO: 2023; IF: 11.1
Luciano AM, Di Martile M, Perez-Oliva AB, Di Caprio M, Foddai ML, Buglioni S, Mulero V, Del Bufalo D. Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment. J Exp Clin Cancer Res. 2023 Jul 24;42(1):178. doi: 10.1186/s13046-023-02735-9. PubMed PMID: 37488586; PubMed Central PMCID: PMC10364435.
AÑO: 2023
Sanchez-Villalobos M, Campos Banos E, Juan Fita MJ, Egea Mellado JM, Gonzalez Gallego I, Beltran Videla A, Berenguer Piqueras M, Bermudez Cortes M, Moraleda Jimenez JM, Guillen Navarro E, Salido Fierrez E, Perez-Oliva AB. A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain). Int J Neonatal Screen. 2023 Oct 10;9(4):55. doi: 10.3390/ijns9040055. PubMed PMID: 37873846; PubMed Central PMCID: PMC10594431.
AÑO: 2023
Gomez-Abellan V, Perez-Oliva AB, Cabas I, Hermi F, Arizcun M, Garcia-Moreno D, Sepulcre MP, Mulero V. Peroxisome proliferator-activated receptors alpha and beta mediate the anti-inflammatory effects of the cyclopentenone prostaglandin 15-deoxy-Delta12,14-PGJ2 in fish granulocytes. Dev Comp Immunol. 2022 Nov;136:104498. doi: 10.1016/j.dci.2022.104498. Epub 2022 Aug 7. PubMed PMID: 35948178.
AÑO: 2022; IF: 2.9

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R